Friedreich ataxia (FRDA) is an inherited degenerative condition caused by GAA trinucleotide repeat expansion in the frataxin gene, causing mitochondrial iron accumulation and neuronal degeneration. It is the most common hereditary ataxia, typically presenting in adolescence or early adulthood with progressive gait ataxia. FRDA is distinguished from many other conditions covered in this series by its onset in young people (average age of onset: 15 years) and its progressive nature.
How Friedreich Ataxia Affects Gait
FRDA causes neurodegeneration in specific anatomical sites relevant to gait:
- Dorsal root ganglia: Sensory neuron loss eliminates proprioceptive input from the legs -- the continuous sensory feedback from joints and muscles that normally guides balance
- Spinocerebellar tracts: Loss of coordination feedback to the cerebellum disrupts the timing and smoothness of movement
- Corticospinal tract involvement: Motor pathway degeneration (later in the disease course) adds weakness to the coordination and sensory deficits
The clinical result is cerebellar ataxia: irregular, unsteady gait with wide stance, irregular step timing, difficulty with direction changes, and progressive balance impairment. Unlike Parkinson disease (where gait is small-stepped and shuffling), FRDA gait is irregular and lurching -- unpredictable in direction.
Walking Cane in Early Friedreich Ataxia
In early FRDA, a walking cane provides:
- A third ground contact point that partially substitutes for lost proprioception -- the ground contact signal through the shaft gives the brain some position information that sensory nerves are no longer providing
- A catch mechanism: the ataxic gait generates lateral sways that a cane can arrest before they progress to a fall
- Rhythm anchor: some ataxia patients find that having a physical rhythm reference (the cane contact rhythm) helps moderate the irregularity of their gait
Limitations and Progression
As FRDA progresses, the coordination impairment makes controlled cane placement progressively harder to achieve. The same coordination deficit that makes walking unstable also affects the arm movement required to place the cane accurately. This is similar to the Huntington disease situation -- at a certain point, the cane cannot be used effectively and actually becomes a fall risk.
Average time from FRDA onset to wheelchair use is approximately 10-15 years, though with significant individual variation. A cane is typically most useful in the first 5-8 years of significant gait involvement.
FRDA Progression and Aid Selection
| FRDA Stage | Gait Characteristic | Appropriate Aid |
|---|---|---|
| Early | Mild ataxia, independent walking | Single cane for safety and proprioceptive supplement |
| Moderate | Significant ataxia, falls beginning | Single cane if arm coordination adequate; assess |
| Moderate-advanced | Severe ataxia, frequent falls | Bilateral canes or rollator |
| Advanced | Unable to walk safely | Wheelchair |
Cardiac Considerations in FRDA
Hypertrophic cardiomyopathy is present in approximately 60-80% of FRDA patients and limits exercise tolerance independently of the neurological component. Energy conservation (as with the cane energy-saving function) is relevant in this context -- reduced metabolic demand per step extends tolerable walking distance when cardiac output is compromised.
View the DaiWalk cane range. Related: Walking Cane for Cerebellar Ataxia | Walking Cane for Huntington Disease
